Aug 29
|
Biden Administration targets drugs from J&J, Merck for controversial Medicare price negotiations
|
Aug 29
|
Why Wegovy's Sales Potential Could Be Massively Understated
|
Aug 28
|
3 Top Growth Stocks I'd Buy Right Now Without Hesitation
|
Aug 28
|
Is It Time to Take Some Gains in Novo Nordisk Stock? Not So Fast.
|
Aug 27
|
Who Would Bet Against Eli Lilly? I Would and Here's How
|
Aug 25
|
How Novo Nordisk, A Top 1% Stock, Just Hit Another Bull's-eye In Obesity Treatment
|
Aug 25
|
Novo Nordisk’s Wegovy Helped Heart-Failure Patients. What’s Next?
|
Aug 25
|
Novo Nordisk (NVO) Posts Upbeat Data From Heart Failure Study
|
Aug 25
|
Novo Nordisk's (NVO) Shares Jump 17% in a Month: Here's Why
|
Aug 25
|
Semaglutide 2.4 mg shows large reductions in heart failure-related symptoms and physical limitations in people with heart failure with preserved ejection fraction and obesity
|
Aug 24
|
Eli Lilly Has A Big Stake In Weight Loss And Alzheimer's Drugs; But Is The Stock A Buy?
|
Aug 24
|
CVS Health launches new brand Cordavis to target $100 billion biosimilar market
|
Aug 24
|
This New Development Is Helping to Send Eli Lilly and Novo Nordisk Stocks Soaring
|
Aug 24
|
Elon Musk once used a weight loss drug to look 'fit, ripped and healthy' — now the company behind it is more valuable than the entire economy of Denmark. Here's what happened
|
Aug 24
|
3 Massive New Markets Could Await Ozempic, And They Might Make Novo Nordisk Investors Richer
|
Aug 24
|
High demand, low supplies for Novo's weight-loss drug launch in Germany
|
Aug 23
|
Why Novo Nordisk Stock Was Racing Higher on Wednesday
|
Aug 23
|
REFILE-Novo hires Thermo Fisher as 2nd manufacturer for Wegovy weight-loss drug - source
|
Aug 22
|
Could This 1 Problem Put a Dent in Novo Nordisk and Eli Lilly Stock?
|
Aug 22
|
Large employers split on covering GLP-1 drugs for weight loss: Survey
|